A detailed history of Marshall Wace, LLP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 524,949 shares of PCRX stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
524,949
Previous 971,143 45.95%
Holding current value
$10.2 Million
Previous $27.8 Million 71.55%
% of portfolio
0.01%
Previous 0.04%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$11.7 - $28.46 $5.22 Million - $12.7 Million
-446,194 Reduced 45.95%
524,949 $7.91 Million
Q2 2024

Aug 14, 2024

BUY
$25.5 - $31.51 $4.07 Million - $5.04 Million
159,791 Added 19.69%
971,143 $27.8 Million
Q1 2024

May 15, 2024

BUY
$27.7 - $35.48 $9.17 Million - $11.7 Million
331,159 Added 68.96%
811,352 $23.7 Million
Q4 2023

Feb 14, 2024

SELL
$26.32 - $34.31 $143,496 - $187,058
-5,452 Reduced 1.12%
480,193 $16.2 Million
Q3 2023

Nov 14, 2023

BUY
$30.68 - $40.09 $2.99 Million - $3.9 Million
97,348 Added 25.07%
485,645 $14.9 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $47.5 $2.5 Million - $3.28 Million
69,136 Added 21.66%
388,297 $15.6 Million
Q1 2023

May 15, 2023

BUY
$35.53 - $43.38 $6.89 Million - $8.41 Million
193,804 Added 154.6%
319,161 $13 Million
Q4 2022

Feb 14, 2023

BUY
$38.19 - $57.45 $3.15 Million - $4.73 Million
82,396 Added 191.79%
125,357 $4.84 Million
Q3 2022

Nov 14, 2022

BUY
$51.24 - $58.89 $1.26 Million - $1.45 Million
24,638 Added 134.46%
42,961 $2.29 Million
Q2 2022

Aug 15, 2022

BUY
$51.49 - $81.64 $943,451 - $1.5 Million
18,323 New
18,323 $1.07 Million
Q1 2022

May 16, 2022

SELL
$60.03 - $76.49 $12.3 Million - $15.7 Million
-205,322 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$47.97 - $62.21 $9.13 Million - $11.8 Million
190,381 Added 1274.22%
205,322 $12.4 Million
Q3 2021

Nov 15, 2021

BUY
$54.64 - $61.3 $816,376 - $915,883
14,941 New
14,941 $837,000
Q2 2021

Aug 13, 2021

SELL
$59.18 - $69.99 $1.81 Million - $2.14 Million
-30,624 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$59.31 - $78.82 $1.82 Million - $2.41 Million
30,624 New
30,624 $2.15 Million
Q1 2020

May 15, 2020

SELL
$28.4 - $50.7 $558,713 - $997,421
-19,673 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$36.31 - $46.83 $9.2 Million - $11.9 Million
-253,489 Reduced 92.8%
19,673 $891,000
Q3 2019

Nov 14, 2019

BUY
$35.66 - $44.99 $9.74 Million - $12.3 Million
273,162 New
273,162 $10.4 Million

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $892M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.